Bird Flu as Next Health Risk for Human Being
DOI:
https://doi.org/10.14738/bjhr.1201.18337Keywords:
Bird flu, hRSV, Influenza, SARS-CoV-2, African coronavirusAbstract
Pepole are protected by H5N1 strains already circulating as well as by vaccinated healthy volunteers. The treat of a new infections from wild bird is spreading among animals that provide us with milk and are causing disease in people. It is possible that the capacity to attache to human cells and then to spread and to develop mutations allowing seasonal fly to exchange genetic information and spreading by a new strain. Therefore the need to develop a new vaccine that could be used in case of outbreak.
References
Tarro G. International online conference of the best virologists from all over the world by the World Health Organization (WHO), September 30, October 1, 2020.
Smith C. Scientists can’t explain puzzling lack of coronavirus outbreaks in Africa. BGR, September 4, 2020.
Tarro G. Different background of immunological response according to previous zoonotic experience with coronavirus. International Journal of Development Research. Vol. 10, Issue 10, October 2020.
Tarro G. The spread of the new coronavirus. Asian Journal of Science and Technology, Vol. 11, Issue 03, pp. 10863-10865, March, 2020.
Arantes de Araújo L, Veloso CF, de Campos Souza M, Coelho de Azevedo JM and Tarro G. The potential impact of the COVID-19 pandemic on child growth and development: a systematic review. Jornal de Pediatria, DOI: 10.1016/ipd.2020.08.008.
Tarro G. Pathogenesis of COVID-19 and the body’s responses. International Journal of Recent Scientific Research, Vol. 11, Issue 03 (D), pp. 37940-37942, March, 2020.
Tarro G. Current events and prospects for the coronavirus epidemic. International Journal of Current Research, Vol 12, Issue 05, pp 11799-11801, May, 2020.
Fan W. et al. A new coronavirus associated with human respiratory disease in China. Nature vol 579, 12 March 2020.
Fauci A., Clifford L. and Redfield R. Covid-19 –Navigating the Uncharted. The New England Journal of Medicine, 11 March 2020.
Karpas A. and Bainbridge D. Passive immunotherapy for coronavirus (SARS-Cov-2). Annals of Medical & Surgical Case Report ISSN:2652-4414, 2020.
Tarro G. Influenza viruses. International Journal of Current Research. Vol 13, Issue 03, March 2021. Tarro, G. (2025). Bird Flu as Next Health Risk for Human Being. British Journal of Healthcare and Medical Research, Vol - 12(01). 316-319.
Tarro G. Western season with epidemic flu, SARS-CoV-2 omicron strains and hRSV. British Journal of Healthcare and Medical Research. Vol 10, N. 2, April 25, 2023, pp 448-453.
The Medical Letter on Drugs and Therapeutics. Vaccino antinfluenzale 2024-25. Year 53, September 16, 2024. N. 19 ((1711 Ed. USA) p. 145.
The Medical Letter on Drugs and Therapeutics. Un nuovo vaccino contro l’RSV per gli adulti di età > 60 anni. Year 53, October 14, 2024. N. 21 (1713 Ed. USA) p. 165.
Tarro G. Migratory phenomenon, bioethics and vaccinations. Advances in Microbiology. 5, 720-723, 2015.
Spencer C. Ebola and a decade of disparities – forging a future for global helath equity. The New England Journal of Medicine. January 23, 2025, pp 313-315.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Giulio Tarro
This work is licensed under a Creative Commons Attribution 4.0 International License.
